Company Shandong Xinhua Pharmaceutical Company Limited Shenzhen S.E.

Equities

000756

CNE000000BG1

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-07-14 pm EDT 5-day change 1st Jan Change
14.41 CNY -1.97% Intraday chart for Shandong Xinhua Pharmaceutical Company Limited -1.57% -29.29%

Business Summary

SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED is a China-based company principally engaged in the development, production and distribution of chemical bulk drugs, preparations and medical intermediates. The Company’s main products include metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, L-dopa, pipemidic acid tablets, compound liquorice tablets and nimodipine tablets. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and others.

Number of employees: 7,104

Sales per Business

HKD in Million2022Weight2023Weight Delta
Preparation
56.2 %
3,714 42.6 % 5,033 56.2 % +35.53%
Chemical Raw Material
38.9 %
3,688 42.3 % 3,478 38.9 % -5.71%
Pharmaceutical Intermediates and Other Products
27.9 %
1,323 15.2 % 2,499 27.9 % +88.87%
Offset
-23.0 %
0 0.0 % -2,059 -23.0 % -

Sales per region

HKD in Million2022Weight2023Weight Delta
China (including Hong Kong)
73.2 %
5,696 65.3 % 6,556 73.2 % +15.10%
Europe
12.6 %
1,234 14.1 % 1,131 12.6 % -8.35%
Americas
9.4 %
1,187 13.6 % 844 9.4 % -28.89%
Others
4.7 %
608 7.0 % 420 4.7 % -30.94%

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 487,407,635 239,031,750 ( 49.04 %) 0 60.55 %
Stock B 1 195,000,000 174,172,200 ( 89.32 %) 0

Shareholders

NameEquities%Valuation
Essence Fund Co., Ltd.
0.0103 %
20,000 0.0103 % 13 807 ¥
HuaAn Fund Management Co., Ltd.
0.002051 %
4,000 0.002051 % 2 761 ¥
JPMorgan Asset Management (China) Co Ltd.
0.002051 %
4,000 0.002051 % 2 761 ¥
NameEquities%Valuation
Shandong State-Owned Asset Sup. & Adm. Commission
54.03 %
241,956,080 54.03 % 482 M ¥
Wei Fang
1.611 %
7,213,386 1.611 % 14 M ¥
Wanjia Asset Management Co., Ltd.
0.6014 %
2,693,415 0.6014 % 5 M ¥
Haitao Yu
0.3094 %
1,385,400 0.3094 % 3 M ¥
Xu Zheng
0.2427 %
1,086,700 0.2427 % 2 M ¥
850,000 0.1898 % 2 M ¥
China Southern Asset Management Co., Ltd.
0.0798 %
357,400 0.0798 % 712 237 ¥
GF Fund Management Co., Ltd.
0.0763 %
341,500 0.0763 % 680 551 ¥
Ning Hou
0.0734 %
328,800 0.0734 % 655 243 ¥
China Asset Management Co., Ltd.
0.0656 %
293,900 0.0656 % 585 693 ¥
NameEquities%Valuation
Shandong State-Owned Asset Sup. & Adm. Commission
52.63 %
20,827,800 52.63 % 42 M ¥
183,150 0.4628 % 364 987 ¥
133,200 0.3366 % 265 445 ¥
133,200 0.3366 % 265 445 ¥

Company contact information

Shandong Xinhua Pharmaceutical Co., Ltd.

No. 1 Lutai Avenue Hi-tech Industry Development Zone

255086, Zibo

+86 53 3216 6666

http://www.xhzy.com
address Shandong Xinhua Pharmaceutical Company Limited(000756)
  1. Stock Market
  2. Equities
  3. 719 Stock
  4. 000756 Stock
  5. Company Shandong Xinhua Pharmaceutical Company Limited